Imeik Technology Development Co Ltd
SZSE:300896

Watchlist Manager
Imeik Technology Development Co Ltd Logo
Imeik Technology Development Co Ltd
SZSE:300896
Watchlist
Price: 201.95 CNY -1.57% Market Closed
Market Cap: 61.2B CNY
Have any thoughts about
Imeik Technology Development Co Ltd?
Write Note

Imeik Technology Development Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Imeik Technology Development Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Imeik Technology Development Co Ltd
SZSE:300896
Accrued Liabilities
ÂĄ116.1m
CAGR 3-Years
52%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accrued Liabilities
ÂĄ2.6B
CAGR 3-Years
49%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Accrued Liabilities
ÂĄ1.1B
CAGR 3-Years
8%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Accrued Liabilities
ÂĄ134.4m
CAGR 3-Years
57%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accrued Liabilities
ÂĄ268.5m
CAGR 3-Years
37%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accrued Liabilities
ÂĄ325.2m
CAGR 3-Years
-8%
CAGR 5-Years
85%
CAGR 10-Years
60%
No Stocks Found

Imeik Technology Development Co Ltd
Glance View

Market Cap
61.1B CNY
Industry
Biotechnology

Imeik Technology Development Co Ltd is a prominent player in the cosmetic medical industry, a sector that has experienced robust growth fueled by rising consumer demand for aesthetic enhancements. Situated in the heart of the beauty-conscious market of China, Imeik specializes in the development, manufacturing, and commercialization of medical aesthetic products, most notably hyaluronic acid fillers. These products, used extensively by dermatologists and beauty clinics, cater to individuals seeking non-invasive procedures to enhance their aesthetic appeal. By leveraging advanced biotechnological methodologies, Imeik has positioned itself as a trusted brand, gaining an edge through continual innovation and adherence to rigorous safety standards. The company's business model revolves around the strategic development and distribution of a diversified portfolio of aesthetic products. Imeik's revenue streams principally derive from the commercialization of its cutting-edge dermal fillers and other complementary medical solutions. By focusing on research and development, the company not only stays ahead of aesthetic trends but also ensures that its offerings maintain a high standard of efficacy and safety, essential in a sensitive market domain like medical aesthetics. Furthermore, Imeik’s collaborations with key stakeholders in the healthcare and cosmetic sectors amplify its reach, solidifying its market position and driving sustainable profitability. Through these endeavors, Imeik effectively captures a slice of the lucrative and rapidly growing beauty market, reinforcing its leadership within the industry.

Intrinsic Value
195.23 CNY
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Imeik Technology Development Co Ltd's Accrued Liabilities?
Accrued Liabilities
116.1m CNY

Based on the financial report for Dec 31, 2023, Imeik Technology Development Co Ltd's Accrued Liabilities amounts to 116.1m CNY.

What is Imeik Technology Development Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
49%

Over the last year, the Accrued Liabilities growth was 40%. The average annual Accrued Liabilities growth rates for Imeik Technology Development Co Ltd have been 52% over the past three years , 49% over the past five years .

Back to Top